Indrayani Biotech Ltd — Important, 16-09-2025: Company Update

Indrayani Biotech Limited announced that IBL Investments Trust, created by its wholly-owned subsidiary IBL Investments Limited, has secured approval from SEBI for a Category II Alternative Investment Fund. This registration allows the trust to operate as a SEBI-regulated Alternative Investment Fund, diversifying the company's business into the alternative investment space. This move could open new avenues for strategic investments and fund management, expanding the group's financial operations and potentially creating new revenue streams for shareholders. The approval is perpetual, signifying a long-term strategic addition to the company's business profile.